RSS Feed Link

eMed Blog

Investing in bioscience for the long haul

Investors in bioscience are looking not just for financial returns, but societal returns over the long haul in a global economy. And that will take collaborative efforts and a crowdsourcing of expertise as well as capital.

[More]
Posted by: Rita Baron-Faust
on November 5, 2013
Why talking to patients is important in developing your app

The founding team behind CyberDoctor wanted to make sure the product addressed a common need before launching it, and talking to patients was crucial to that.

[More]
Posted by: Ryan Amin
on November 5, 2013
Category:  Creation 
Wall Street Journal's advice on patents

When a startup gets ready for some M&A action (and if they're in healthcare, getting to this point was probably hard-fought and hard-won), a patent troll could come knocking. While the Federal Trade Commission is finally looking into patent trolls' effect on innovation, patent trolls still lurk, according to a blog in the Wall Street Journal.

[More]
Posted by: MedCityNews .com
on November 4, 2013
Category:  Creation 
eMed's 6 to follow in entrepreneurship

See who made this week's 6 to follow in entrepreneurship

[More]
Posted by: Ryan Amin
on November 1, 2013
Category:  Execution  Creation  Ideation  Growth 
The right questions to ask about your company’s intellectual property

Intellectual property is one of the toughest subjects for life science and digital health entrepreneurs to understand. From dealing with the tech transfer office to hiring an attorney to filing a provisional patent, IP is a common stumbling block for early-stage entrepreneurs.

[More]
Posted by: Christina Hernandez Sherwood
on October 31, 2013
Category:  Creation 
What comes after the idea?

At a Life Science Ventures Summit hosted by the Kauffman Foundation, Huffington Post writer Jennifer Hill led a discussion focused on the players in entrepreneurship (0:11:57 - 0:14:52). The panel included Nick Franano, Avi Roop, Geoff Clapp and Sofie Qiao.

[More]
Posted by: Ryan Amin
on October 31, 2013
Category:  Ideation  Creation 
What scares away investors?

I think few things could be more rewarding than investing in a company that develops a cure or effective treatment for any of the hundreds of conditions that affect millions of people with no effective treatment. But finding the right company can be fraught with risk. That's one reason why angel and venture investors have been allocating funds to later stage companies that carry less risk.

[More]
Posted by: MedCityNews .com
on October 30, 2013
Category:  Growth  Creation 
How to get your medical device accepted for use in hospitals

In healthcare innovation, fixing a problem is not enough for a product to become a standard in the industry.

[More]
Posted by: Ryan Amin
on October 29, 2013
Category:  Creation  Execution 
Medical device companies can learn from Starbucks

As global medical device companies try to take on more of the care continuum, they might be able to turn to that little Starbucks coffee shop just around the corner. It might seem sacrilege to compare the intricacies of neuromodulator with a perfectly brewed, expertly crafted cup of joe, but here I find myself. Why? Because it's not just medtech's products that need to become more innovative, but its business model as well.

[More]
Posted by: MedCityNews .com
on October 28, 2013
Category:  Growth 
eMed's 6 to follow in entrepreneurship

See who made this week's 6 to follow in entrepreneurship.

[More]
Posted by: Ryan Amin
on October 25, 2013
Category:  Creation  Growth  Execution  Ideation